Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3048 results

Sort By:

Post-market Evaluation of the Transition From the Baha Connect System to the Osia System in Adult Bone Conduction Implant Recipients

Study ID: NCT07130136
Start Date: 2026-05
End Date: 2028-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Cochlear™ Osia® System

Cochlear™ Baha® System

Sponsor

Cochlear

Source: clinicaltrials.gov

Share:
Add to list

Grid eXplore Mapping Study

Study ID: NCT07421076
Start Date: 2026-03-31
End Date: 2028-01-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Grid X and EnSite X v3.1.1 Software

Sponsor

Abbott Medical Devices

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of the HeartLogic Diagnostic in Optimizing Guideline-directed Medical Therapy in Patients With Congestive Heart Failure and Chronically Low Ejection Fractions (EFs)

Study ID: NCT07412626
Start Date: 2026-04-01
End Date: 2028-03
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

135

Intervention / Treatment

Heartlogic Diagnostic Tool Threshold Change

Heartlogic Diagnostic Tool Unchanged Threshold

Sponsor

Robert Pickett

Source: clinicaltrials.gov

Share:
Add to list

Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Patients - WINDOW-4 Study

Study ID: NCT07257055
Start Date: 2026-05-12
End Date: 2030-11-24
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Acalabrutinib

Rituximab

Glofitamab

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Prospective AnalysiS of Self medIcation With phytOtherapy in Nephropatic Patients.

Study ID: NCT07444515
Start Date: 2026-04-02
End Date: 2028-07-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment

series of questions which can change patient care

Sponsor

Reunion University Hospital Center

Source: clinicaltrials.gov

Share:
Add to list

Phase II Trial of Sacituzumab Tirumotecan in Patients With SMARCB1-Deficient Renal Medullary Carcinoma

Study ID: NCT07438626
Start Date: 2026-06-01
End Date: 2030-02-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Sacituzumab tirumotecan

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

PEP Buddy in Pulmonary Rehabilitation

Study ID: NCT07404826
Start Date: 2026-04-01
End Date: 2030-03-29
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

PEP Buddy

PEP Buddy Sham

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Immunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 Levels

Study ID: NCT07360743
Start Date: 2026-04
End Date: 2032-04
Study Type

Interventional

Study Phase

Phase2

No. of Participants

275

Intervention / Treatment

Pembrolizumab

Cemiplimab

Sponsor

UNICANCER

Source: clinicaltrials.gov

Share:
Add to list

ProofPrinciple IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophageal Adenocarcinoma w/ARID1a In

Study ID: NCT06824363
Start Date: 2026-04
End Date: 2028-07
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

34

Intervention / Treatment

Tremelimumab

Durvalumab

Sponsor

University of California, Irvine

Source: clinicaltrials.gov

Share:
Add to list

Pembrolizumab + MRGOO3 as Neoadjuvant in NPC

Study ID: NCT07267338
Start Date: 2026-06
End Date: 2029-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

35

Intervention / Treatment

Pembrolizumab & MRG003

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Source: clinicaltrials.gov

Share:
Add to list